Use of bar-code technology drastically reduces medication errors
Using bar-code verification technology within an electronic medication administration system substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a new study.
Using bar-code verification technology within an electronic medication administration system (bar-code eMAR) substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a study from Brigham and Women's Hospital.
Investigators observed more than 14,000 medication administrations and reviewed more than 3,000 order transcriptions at Brigham and Women's Hospital.
In hospital units that did not use the bar-code eMAR, researchers observed 776 nontiming errors in medication administration (11.5% error rate) compared with 495 such errors (6.8% error rate) on units used the technology-a 41% relative reduction in errors (P<.001).
In addition, although transcription errors occurred at a rate of 6.1% on units without bar-code eMAR, they were completely eliminated on units that did use the technology.
Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362(18):1698-1707.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
